Research

Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5081109/

Learn more
Autoimmune encephalopathies in children: diagnostic clues and therapeutic challenges February 27, 2021

http://nnjournal.net/article/showpdf/1324/1037

Learn more
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A new challenging entity for consultation-liaison psychiatrist February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959779/

Learn more
Autoantibody-associated central nervous system neurologic disorders February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/27643908

Learn more
Antibody-associated epilepsies: Clinical features, evidence for immunotherapies and future research questions February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042290/

Learn more
Antibody-mediated autoimmune encephalitis in children February 27, 2021

http://www.pedneur.com/article/S0887-8994(15)30139-9/fulltext

Learn more
Autoimmune encephalitis in psychiatric institutions: current perspectives February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089825/

Learn more
Autoimmune movement disorders February 27, 2021

https://www.sciencedirect.com/science/article/pii/B9780444634320000177?via%3Dihub

Learn more
Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up February 27, 2021

https://www.ncbi.nlm.nih.gov/pubmed/27590293

Learn more
Current and future immunotherapy targets in autoimmune neurology February 27, 2021

https://www.sciencedirect.com/science/article/pii/B978044463432000027X?via%3Dihub

Learn more